Avitas Wealth Management LLC Trims Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avitas Wealth Management LLC lowered its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,866 shares of the medical equipment provider’s stock after selling 43 shares during the quarter. Avitas Wealth Management LLC’s holdings in Intuitive Surgical were worth $974,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp lifted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the period. FMR LLC boosted its position in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC lifted its stake in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. boosted its holdings in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.2 %

Shares of NASDAQ:ISRG opened at $579.65 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market cap of $206.46 billion, a P/E ratio of 90.43, a PEG ratio of 5.51 and a beta of 1.39. The business has a fifty day moving average of $551.24 and a two-hundred day moving average of $511.16.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 in the last ninety days. 0.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.